Aaron posted some information regarding the shareh
Post# of 154158
(Total Views: 718)
Posted On: 03/11/2022 7:00:04 PM
Aaron posted some information regarding the shareholder's lawsuit and the SEC/DOJ subpoenas (motion to dismiss). It's worth sharing:
Aaron5 hours ago
Shareholders lawsuit and SEC/DOJ
"I have NOT had time to read the documents on Pacer however they have descriptors to what is contained in the documents (which anyone can read for free).
It appears from the descriptors that Cytodyn filed a motion to dismiss the shareholders case and this motion was supported by the "discovery" sent to SEC/DOJ in relation to the subpeonas received as noted in their 8K.
Basically, Cytodyn is claiming their answers to the SEC/DOJ are satisfactory enough to make the lawsuit by shareholders moot and dismissable.
Which sounds like Cytodyn is pretty confident about their handling of SEC/DOJ subpeonas enough to use it against the shareholders lawsuit.
The last action listed on Pacer for the shareholders lawsuit is that the schedule for dismissal has been stayed to allow the shareholders plaintiffs attorneys time to examine the answers supplied to the SEC/DOJ.
Again, without reading the documents, it appears from the Pacer descriptors that Cytodyn is killing two birds with one stone. Addressing the SEC/DOJ subpeonas with satisfaction and using those to dismiss claims of wrongdoing with the shareholders lawsuit.
When I get a chance in the next few days to read the documents and if there is anything new to add I will."
Aaron5 hours ago
Shareholders lawsuit and SEC/DOJ
"I have NOT had time to read the documents on Pacer however they have descriptors to what is contained in the documents (which anyone can read for free).
It appears from the descriptors that Cytodyn filed a motion to dismiss the shareholders case and this motion was supported by the "discovery" sent to SEC/DOJ in relation to the subpeonas received as noted in their 8K.
Basically, Cytodyn is claiming their answers to the SEC/DOJ are satisfactory enough to make the lawsuit by shareholders moot and dismissable.
Which sounds like Cytodyn is pretty confident about their handling of SEC/DOJ subpeonas enough to use it against the shareholders lawsuit.
The last action listed on Pacer for the shareholders lawsuit is that the schedule for dismissal has been stayed to allow the shareholders plaintiffs attorneys time to examine the answers supplied to the SEC/DOJ.
Again, without reading the documents, it appears from the Pacer descriptors that Cytodyn is killing two birds with one stone. Addressing the SEC/DOJ subpeonas with satisfaction and using those to dismiss claims of wrongdoing with the shareholders lawsuit.
When I get a chance in the next few days to read the documents and if there is anything new to add I will."
(9)
(0)